Sign Out
Capsule: Short-term (4-8 weeks) treatment in the healing and symptomatic relief of erosive or ulcerative gastroesophageal reflux disease (GERD).
Maintenance for healing and reduction in relapse rates of heartburn symptoms in patients with erosive or ulcerative GERD.
Short-term (up to 4 weeks) treatment in the healing and symptomatic relief of duodenal ulcers. Most patients heal within 4 weeks.
Long-term treatment of pathological hypersecretory conditions including Zollinger-Ellison syndrome.
Injection: It is an alternative in patients for whom oral administration of rabeprazole is not indicated. Treatment of active duodenal ulcer with bleeding or severe erosions; active gastric ulcer with bleeding or severe erosions; short-term treatment of erosive or ulcerative gastroesophageal reflux disease (GERD); prevention of acid-aspiration during surgery; prevention of stress-induced mucosal injury in critical care; pathological hypersecretory conditions, including Zollinger-Ellison syndrome.
